Cardima Pathfinder
This article was originally published in The Gray Sheet
Executive Summary
Minimally invasive microcatheter clears FDA via 510(k) for the diagnosis of ventricular tachycardia, the company announces July 9. Freemont, California-based Cardima says the product is the smallest available microcatheter for the diagnosis of VT, and can access areas of the heart currently inaccessible by traditional catheter technology